BACKGROUND: @entity6425 is a major cause of childhood @entity294 in Libya. The objective of this study is to evaluate the cost-effectiveness of rotavirus vaccination in that country. METHODS: We used a published decision tree model that has been adapted to the Libyan situation to analyze a birth cohort of 160,000 @entity1 . The evaluation of @entity294 events in three public hospitals helped to estimate the rotavirus burden. The economic analysis was done from two perspectives: health care provider and societal. Univariate sensitivity analyses were conducted to assess uncertainty in some values of the variables selected. RESULTS: The three hospitals received 545 @entity294 @entity1 aged <=5 with 311 (57%) rotavirus positive test results during a 9-month period. The societal cost for treatment of a case of rotavirus @entity294 was estimated at US  661/event. The incremental cost-effectiveness ratio with a vaccine price of US  27 per course was US  8,972 per quality-adjusted life year gained from the health care perspective. From a societal perspective, the analysis shows cost savings of around US  16 per @entity1 . CONCLUSION: The model shows that rotavirus vaccination could be economically a very attractive intervention in Libya.

Cost-effectiveness analysis of rotavirus vaccination among Libyan XXXX using a simple economic model.

@entity1 :: ('9606', 'Species') :: ['children', 'patients', 'child'] @entity6425 :: ('MESH:D012400', 'Disease') :: ['Rotavirus infection'] @entity294 :: ('MESH:D003967', 'Disease') :: ['diarrhea']
@entity1 :: (9606,Species) :: ['children']
